• Prostaglandin signaling and myometrial contractility emerged as a central theme, uniting exogenous PGF2α/PGE2 responses, endogenous PGF2α levels, local PG delivery, and NSAID modulation of contractions across studies. [1] [3] [13] [19] [18] [9]

• Estrogen and progesterone regulate uterine remodeling and ECM dynamics via estrogen-driven collagenase regulation, latent collagenase activation, and decidualization cues shaping tissue turnover and receptivity. [6] [11] [7]

• Estrogen signaling influences uterine perfusion and prostaglandin biology by stimulating uterine blood flow, directing prostaglandin synthesis, and binding estrogen in uterine cytosols. [2] [9] [8]

• Clinical epidemiology and pathology patterns reveal management and disease patterns in uterine conditions, including hysterectomy surveillance programs and fibroid-related neoplasia or erythropoietin-producing fibromyomas. [5] [15] [17] [20]

• Endometrial assessment and contractility studies illustrate endometrium-uterine function links and methodological approaches to sampling and decidual/contractile states. [4] [14]